Journals / Klinik Tıp Pediatri Dergisi / 2017 / Cilt: 9 - Sayı: 2

Management of Asthma Exacerbation

Astım Atak Tedavisi

Pages
24–31
Publication Date
2017-03-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While determining the treatment choice patient’s age isan important variable.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractAsthma is the most prevalent chronic disease in childhood.
📊
Key Findings & Data:Increased treatmentcost, anxiety among parents and missed school days for children is other adverse events that are caused by asthma exacerbations.
💡
Conclusion & Impact:While determining the treatment choice patient’s age isan important variable.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:astım atağı · akut astım · tedavi

Abstract

AbstractAsthma is the most prevalent chronic disease in childhood. With our current treatment options asthma is not a curable disease, so it is not avoidable for asthma patients to seek medical care for exacerbations. Asthma exacerbation is a major cau-se for patients to visit emergency services and may even cause hospitalization. Increased treatmentcost, anxiety among parents and missed school days for children is other adverse events that are caused by asthma exacerbations. Quick anamnesis, physical examination and evaluation of frequency of exacerbations followed by quick ini-tiation of the therapy, is the simple algorithm for approaching asthma exacerbations.Children who are older than 5 years differ both anatomically and physiologically from younger ones, this changes controlling-therapy as well as exacerbation-therapy approach for these patients. While determining the treatment choice patient’s age isan important variable.

Özet

ÖzAstım; çocukluk çağının en sık kronik hastalığıdır. Günümüzde halen astım has-talığını ortadan kaldıracak bir tedavi olmaması nedeni ile astım hastalarının atak yakınmaları ile karşımıza çıkmaları kaçınılmazdır. Astım atakları acil servis başvuruları ve hastane yatışlarının önemli bir sebebidir. Aynı zamanda çocukların okul kaybına, ailelerde endişeye ve tedavi masraflarında artışa neden olmaktadır. Atakta olan her hastanın öncelikle kısa öyküsü alınarak, muayenesi yapılmalı veatak şiddeti belirlenmelidir. Ardından hızlıca hastanın tedavisine başlanmalıdır. Beş yaş altında ve üstünde olan çocukların anatomik ve fizyolojik özellikleri birbirinden oldukça farklı olduğundan hem kronik astım tedavisi hem de atak sırasında yapılması gerekenler bazı farklılıklar göstermektedir. Tedavi planı belirlenirkenhastanın yaşı göz önünde bulundurulmalıdır.

🔖

Cite This Article

GÜLER, P. D. N. (2017). Management of Asthma Exacerbation. Klinik Tıp Pediatri Dergisi, Cilt: 9 - Sayı: 2, 24–31. https://ajindex.com/articles/838419

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kaynaklar 1.http://www.cdc.gov/nchs/FASTATS/asthma.htm [accessed09.03.09]. 2.Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA,Busse WW, at al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exa-cerbations: standardizing endpoints for clinical asthma tri-als and clinical practice. Am J Respir Crit Care Med.2009;180:59-99. 3.Guidelines for the Diagnosis and Management of Asthma (Ex-pert Panel Report 3) National Heart, Lung,and Blood Insti-tute-2007. 4.Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, GernJ, Lemanske R, at al. International consensus on (ICON) pe-diatric asthma. Allergy. 2012; 67:976-97. 5.Hançerli-Törün S, Özçeker D, Uysalol M, Tamay Z, Şık G, So-mer A, et al. Predictive factor for first wheezing episode. TurkJ Pediatr. 2015 Jul-Aug;57(4):367-73. 6.Global Initiative for Asthma (GINA) Program 2016. www.gi-naasthma.org 7.Brunette MG1, Lands L, Thibodeau LP. Childhood asthma: pre-vention of attacks with short-term corticosteroid treatment ofupper respiratory tract infection. Pediatrics. 1988;81:624-9. 8.Fox GF1, Marsh MJ, Milner AD.Treatment of recurrent acu-te wheezing episodes in infancy with oral salbutamol and pred-nisolone. Eur J Pediatr.1996;155:512-6. 9.Grant CC1, Duggan AK, DeAngelis C. Independent parental ad-ministration of prednisone in acute asthma: a double-blind, pla-cebo-controlled, crossover study. Pediatrics. 1995;96:224-9. 10.Oommen A, Lambert PC, Grigg J. Efficacy of a short cour-se of parent-initiated oral prednisolone for viral wheeze inchildren aged 1-5 years: randomised controlled trial. Lancet.2003;362:1433-8. 11.Vuillermin P, South M, Robertson C. Parent-initiated oral cor-ticosteroid therapy for intermittent wheezing illnesses in child-ren. Cochrane Database Syst Rev. 2006;19:CD005311. 12.Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buch-vald F. Intermittent inhaled corticosteroids in infants with epi-sodic wheezing. N Engl J Med. 2006 11;354:1998-2005. 13.Connett G, Lenney W. Prevention of viral induced asthma attacksusing inhaled budesonide. Arch Dis Child. 1993;68:85-7. 14.Ducharme FM1, Lemire C, Noya FJ, Davis GM, Alos N, Leb-lond H, et all. Preemptive use of high-dose fluticasone for vi-rus-induced wheezing in young children. N Engl J Med.2009;360:339-53. 15.Zeiger RS, Mauger D, Bacharier LB, Guilbert TW, MartinezFD, Lemanske RF, at al. Daily or intermittent budesonide inpreschool children with recurrent wheezing. N Engl J Med.2011;365:1990-2001. 16.Ch